ResMed Inc. reported earnings results for the second quarter and six months ended December 31, 2021. For the second quarter, the company reported sales was USD 894.87 million compared to USD 800.01 million a year ago. Net income was USD 201.75 million compared to USD 179.51 million a year ago. Basic earnings per share from continuing operations was USD 1.38 compared to USD 1.24 a year ago. Diluted earnings per share from continuing operations was USD 1.37 compared to USD 1.23 a year ago.
For the six months, sales was USD 1,798.89 million compared to USD 1,551.96 million a year ago. Net income was USD 405.36 million compared to USD 357.89 million a year ago. Basic earnings per share from continuing operations was USD 2.78 compared to USD 2.47 a year ago. Diluted earnings per share from continuing operations was USD 2.76 compared to USD 2.45 a year ago.